Sharina Hamzah - Search Results

Year	Number of Results
2013	2
2014	1
2023	4
2024	2

1

Novel drug candidates against antibiotic-resistant microorganisms: A review.

Lim JS, Chai YY, Ser WX, Haeren AV, Lim YH, Raja T, Foo JB, Hamzah S, Sellappans R, Yow HY. Lim JS, et al. Among authors: hamzah s. Iran J Basic Med Sci. 2024;27(2):134-150. doi: 10.22038/IJBMS.2023.71672.15593. Iran J Basic Med Sci. 2024. PMID: 38234674 Free PMC article. Review.

2

Pharmacogenomics of response to statin treatment and susceptibility to statin-induced adverse drug reactions in Asians: a scoping review.

Yow HY, Hamzah S, Abdul Rahim N, Suppiah V. Yow HY, et al. Among authors: hamzah s. Asian Biomed (Res Rev News). 2023 Oct 9;17(3):95-114. doi: 10.2478/abm-2023-0050. eCollection 2023 Jun. Asian Biomed (Res Rev News). 2023. PMID: 37818163 Free PMC article. Review.

3

Small Extracellular Vesicles' miRNAs: Biomarkers and Therapeutics for Neurodegenerative Diseases.

Lim WQ, Michelle Luk KH, Lee KY, Nurul N, Loh SJ, Yeow ZX, Wong QX, Daniel Looi QH, Chong PP, How CW, Hamzah S, Foo JB. Lim WQ, et al. Among authors: hamzah s. Pharmaceutics. 2023 Apr 11;15(4):1216. doi: 10.3390/pharmaceutics15041216. Pharmaceutics. 2023. PMID: 37111701 Free PMC article. Review.

4

The Effects and Mechanisms of Xanthones in Alzheimer's Disease: A Systematic Review.

Pang LW, Hamzah S, Tan SLJ, Mah SH, Yow HY. Pang LW, et al. Among authors: hamzah s. Neurochem Res. 2023 Dec;48(12):3485-3511. doi: 10.1007/s11064-023-04005-8. Epub 2023 Aug 14. Neurochem Res. 2023. PMID: 37578655 Review.

5

Targeting Mutant-p53 for Cancer Treatment: Are We There Yet?

Lim DV, Woo WH, Lim JX, Loh XY, Soh HT, Lim SYA, Lee ZY, Yow HY, Hamzah SB, Sellappans R, Foo JB. Lim DV, et al. Among authors: hamzah sb. Curr Mol Pharmacol. 2024;17(1):e140923221042. doi: 10.2174/1874467217666230914090621. Curr Mol Pharmacol. 2024. PMID: 37711005 Review.

6

The Cutting-edge of CRISPR for Cancer Treatment and its Future Prospects.

Kah Man L, An Gie O, Chian Huey M, Yong P, Siik Kee L, Cheng Ze L, Ming Yu T, Foo JB, Hamzah S. Kah Man L, et al. Among authors: hamzah s. Curr Pharm Biotechnol. 2023 Oct 25. doi: 10.2174/0113892010258617231020062637. Online ahead of print. Curr Pharm Biotechnol. 2023. PMID: 37921129

7

Potential of dihydropyrimidine dehydrogenase genotypes in personalizing 5-fluorouracil therapy among colorectal cancer patients.

Teh LK, Hamzah S, Hashim H, Bannur Z, Zakaria ZA, Hasbullani Z, Shia JK, Fijeraid H, Md Nor A, Zailani M, Ramasamy P, Ngow H, Sood S, Salleh MZ. Teh LK, et al. Among authors: hamzah s. Ther Drug Monit. 2013 Oct;35(5):624-30. doi: 10.1097/FTD.0b013e318290acd2. Ther Drug Monit. 2013. PMID: 23942539

8

Pharmacogenotyping of CYP3A5 in predicting dose-adjusted trough levels of tacrolimus among Malaysian kidney-transplant patients.

Hamzah S, Teh LK, Siew JS, Ahmad G, Wong HS, Zakaria ZA, Salleh MZ. Hamzah S, et al. Can J Physiol Pharmacol. 2014 Jan;92(1):50-7. doi: 10.1139/cjpp-2013-0128. Epub 2013 Dec 19. Can J Physiol Pharmacol. 2014. PMID: 24383873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year